Stocks and Investing Stocks and Investing
Wed, September 6, 2017
Tue, September 5, 2017
Fri, September 1, 2017
Thu, August 31, 2017
Wed, August 30, 2017
Tue, August 29, 2017
Mon, August 28, 2017
Fri, August 25, 2017
Thu, August 24, 2017
Wed, August 23, 2017
Tue, August 22, 2017
Mon, August 21, 2017
Fri, August 18, 2017
Thu, August 17, 2017

Amit Hazan Initiated (ABT) at Hold and Held Target at $53 on, Aug 17th, 2017


Published on 2024-10-25 22:25:42 - WOPRAI, Amit Hazan
  Print publication without navigation


Amit Hazan of Citigroup, Initiated "Abbott Laboratories" (ABT) at Hold and Held Target at $53 on, Aug 17th, 2017.

Amit has made no other calls on ABT in the last 4 months.



There are 5 other peers that have a rating on ABT. Out of the 5 peers that are also analyzing ABT, 2 agree with Amit's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • David Lewis of "Morgan Stanley" Maintained at Hold with Increased Target to $49 on, Monday, July 10th, 2017
  • Isaac Ro of "Goldman Sachs" Initiated at Hold and Held Target at $45 on, Tuesday, May 16th, 2017


These are the ratings of the 3 analyists that currently disagree with Amit


  • Brittany Henderson of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $56 on, Friday, July 21st, 2017
  • David Toung of "Argus Research" Maintained at Strong Buy with Increased Target to $62 on, Friday, July 21st, 2017
  • Christopher Pasquale of "Guggenheim" Initiated at Strong Buy and Held Target at $58 on, Thursday, June 29th, 2017